Aavant Research vs Peptime
Independent side-by-side comparison across the 0 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Aavant Research
A grades on Tirzepatide (9 tests, avg 8.7) and Semaglutide (11 tests). Tighter score consistency than top peers.
Aavant Research full review →Peptime
BPC-157 specialist. 2 tests averaging 7.5 (purity 98.4–99.0%).
Peptime full review →Side-by-side breakdown
| PEPTIDE | AAVANT RESEARCH | PEPTIME | WINNER |
|---|---|---|---|
| Tirzepatide |
8.7
B+ (9 tests)
|
—(not sold)
|
Aavant Research only |
| Retatrutide |
8.5
B+ (8 tests)
|
—(not sold)
|
Aavant Research only |
| Semaglutide |
8.5
B+ (11 tests)
|
—(not sold)
|
Aavant Research only |
| Ipamorelin |
8.2
B+ (5 tests)
|
—(not sold)
|
Aavant Research only |
| BPC-157 |
—(not sold)
|
7.5
B+ (2 tests)
|
Peptime only |
Which to choose
Across the 0 peptides both vendors sell, Aavant Research scores higher on 0, Peptime scores higher on 0, and 0 are within 0.3 points (effectively tied). Peptime additionally sells BPC-157; Aavant Research does not. Aavant Research additionally sells Tirzepatide, Retatrutide, Semaglutide, Ipamorelin; Peptime does not.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Aavant Research review · Peptime review